Selim F, Baig M, Magoury M, Ahmed W, Mahmoud M
Arch Acad Emerg Med. 2024; 13(1):e16.
PMID: 39670239
PMC: 11635537.
DOI: 10.22037/aaem.v13i1.2470.
Nagge J, Moussa M, Zerai A, Champigny J, Woodill L
Can Pharm J (Ott). 2024; 158(2):83-89.
PMID: 39649478
PMC: 11618838.
DOI: 10.1177/17151635241291854.
Kujawowicz K, Mironczuk-Chodakowska I, Cyunczyk M, Witkowska A
Nutrients. 2024; 16(15).
PMID: 39125416
PMC: 11314023.
DOI: 10.3390/nu16152537.
Gobezie M, Tesfaye N, Solomon T, Demessie M, Wendie T, Belayneh Y
Front Endocrinol (Lausanne). 2024; 15:1399944.
PMID: 38872966
PMC: 11169802.
DOI: 10.3389/fendo.2024.1399944.
Rodrigues R, Gomes G, Sodre B, Lima R, Barros D, Figueiredo A
Cad Saude Publica. 2024; 40(5):e00016423.
PMID: 38775606
PMC: 11111166.
DOI: 10.1590/0102-311XEN016423.
Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic.
Under D, Enver C, Demirci M, Ayhan Y, Ozgan B, Ilerler E
Turk J Pharm Sci. 2024; 21(2):152-158.
PMID: 38742835
PMC: 11096785.
DOI: 10.4274/tjps.galenos.2023.47105.
A primer on quality measurement and reporting in pharmacy benefit plans.
Kogut S
J Manag Care Spec Pharm. 2024; 30(4):386-396.
PMID: 38427331
PMC: 10981972.
DOI: 10.18553/jmcp.2024.23240.
Evaluation of a pharmacist-led intervention to reduce drug-related problems in patients included in a home healthcare program: study protocol for a pragmatic randomized clinical trial.
Salom-Garrigues C, Aragones E, Giralt M, Campabadal Prats C, Bejarano-Romero F, Canadell L
BMC Geriatr. 2024; 24(1):170.
PMID: 38373937
PMC: 10875819.
DOI: 10.1186/s12877-024-04763-2.
Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations.
Collins J, Hu J, McMillan S, OReilly C, El-Den S, Kelly F
J Pharm Policy Pract. 2023; 16(1):133.
PMID: 37919809
PMC: 10621197.
DOI: 10.1186/s40545-023-00637-x.
Acceptance rate of clinical pharmacists' recommendations-an ongoing journey for integration.
Peled O, Vitzrabin Y, Beit Ner E, Lazaryan M, Berlin M, Barchel D
Front Pharmacol. 2023; 14:1253990.
PMID: 37781706
PMC: 10535001.
DOI: 10.3389/fphar.2023.1253990.
Risk factors for medication-related short-term readmissions in adults - a scoping review.
Schonenberger N, Meyer-Massetti C
BMC Health Serv Res. 2023; 23(1):1037.
PMID: 37770912
PMC: 10536731.
DOI: 10.1186/s12913-023-10028-2.
Evaluation of the Prevalence and Risk Factors of Drug-Related Problems in Hypertension and Type 2 Diabetes Mellitus Patients at a Tertiary Care Hospital: A Cross-Sectional Study.
Reddy Peddi D, Pallekonda H, Reddy V
Cureus. 2023; 15(7):e42775.
PMID: 37663988
PMC: 10469343.
DOI: 10.7759/cureus.42775.
Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication-A Systematic Review.
Pereira-Cespedes A, Jimenez-Morales A, Palomares-Bayo M, Martinez-Martinez F, Angel Calleja-Hernandez M
J Clin Med. 2023; 12(15).
PMID: 37568483
PMC: 10419351.
DOI: 10.3390/jcm12155080.
A Clinical Pharmacist-led Approach on Reducing Drug Related Problems Among Patients with Neurological Disorders: An Interventional Study.
Jimmy N, Upadhya M, Jaison J, Sidheque S, Sundaramurthy H, Nemichandra S
Explor Res Clin Soc Pharm. 2023; 11:100302.
PMID: 37538991
PMC: 10393785.
DOI: 10.1016/j.rcsop.2023.100302.
Identifying older adults at increased risk of medication-related readmission to hospital within 30 days of discharge: development and validation of a risk assessment tool.
Glans M, Kempen T, Jakobsson U, Kragh Ekstam A, Bondesson A, Midlov P
BMJ Open. 2023; 13(8):e070559.
PMID: 37536970
PMC: 10401249.
DOI: 10.1136/bmjopen-2022-070559.
Strategies for Avoiding Typical Drug-Drug Interactions and Drug-Related Problems in Patients with Vascular Diseases.
Schmelzer K, Liebetrau D, Kammerer W, Meisinger C, Hyhlik-Durr A
Medicina (Kaunas). 2023; 59(4).
PMID: 37109738
PMC: 10142821.
DOI: 10.3390/medicina59040780.
pH-Responsive Water-Soluble Chitosan Amphiphilic Core-Shell Nanoparticles: Radiation-Assisted Green Synthesis and Drug-Controlled Release Studies.
Piroonpan T, Rimdusit P, Taechutrakul S, Pasanphan W
Pharmaceutics. 2023; 15(3).
PMID: 36986708
PMC: 10052151.
DOI: 10.3390/pharmaceutics15030847.
Pharmacists' clinical roles and activities in inpatient hospice and palliative care: a scoping review.
Wernli U, Hischier D, Meier C, Jean-Petit-Matile S, Kobleder A, Meyer-Massetti C
Int J Clin Pharm. 2023; 45(3):577-586.
PMID: 36773207
PMC: 9918816.
DOI: 10.1007/s11096-023-01535-7.
Pharmacist-led medication reviews in primary healthcare for adult community-dwelling patients - a descriptive study charting a new target group.
Wickman K, Dobszai A, Modig S, Borgstrom Bolmsjo B, Caleres G, Lenander C
BMC Prim Care. 2022; 23(1):237.
PMID: 36114459
PMC: 9482154.
DOI: 10.1186/s12875-022-01849-x.
Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm.
Lam J, Barras M, Scott I, Long D, Hanjani L, Falconer N
Drugs Aging. 2022; 39(5):333-353.
PMID: 35597861
PMC: 9135775.
DOI: 10.1007/s40266-022-00940-3.